A 2016 study “to investigate neurological short-term effects of craniosacral therapy as an ideal form of osteopathic manipulative treatment (OMT) due to the soft kinaesthetic stimulation. Included were 30 preterm infants, with a gestational age between 25 and 33 weeks, who were admitted to the neonatal intensive care unit of the University Hospital of Graz, Austria. The infants were randomized either into the intervention group (IG) which received standardised craniosacral therapy, or the control group (CG) which received standard care. To guarantee that only preterm infants with subsequent normal neurodevelopment were included, follow up was done regularly at the corrected age (= actual age in weeks minus weeks premature) of 12 and 24 months. After 2 years 5 infants had to be excluded (IG; n = 12; CG: n = 13).”
Study concludes “We were able to indicate that a group of “healthy” preterm infants undergoing an intervention with craniosacral therapy (IG) showed no significant changes in GMs compared to preterm infants without intervention (CG). In view of the fact that the global GMA (primary outcome) showed no difference between groups and the GMOS (detailed GMA-secondary outcome) did not deteriorate in the IG, craniosacral therapy seems to be safe in preterm infants.”
Research: Wolfgang Raith et al. “General Movements in preterm infants undergoing craniosacral therapy: a randomised controlled pilot-trial.” BMC Complementary and Alternative Medicine. January 2016, 16:12.
Author: Samantha Lotti
Samantha Lotti is the founder of Biodynamic Health and creator of Body Compassing. She is a certified and registered Biodynamic Craniosacral Therapist (BCST, RCST®), licensed acupuncturist (L.Ac.) and board certified herbalist in Oak Park, Illinois. A personal back injury brought Samantha to biodynamic craniosacral therapy and ignited her interest in a variety of healing modalities.